Government News

The National Pharmaceutical Pricing Authority fixes/revises the price of the Scheduled formulation.

The scheduled formulations are: Atorvastatin + Aspirin Capsule (Atchol-ASP 150), Nifedipine + Lidocaine Cream (LOXHEAL), Pioglitazone + Gliclazide + Metformin Tablet (GLZ Total), Ibuprofen + Paracetamol Tablet (Brufen Plus), Misoprostol Tablet, Glimepiride + Metformin Tablet, Melphalan + Povidone Injection (Melphalan Injection IP 50mg), Trastuzumab Injection, Vitamin D3
(Cholecalciferol) (DRISE SURE), Furosemide Injection, Snake Venom Antiserum-Soluble/ Liquid Polyvalent Injection, and Phenobarbitone oral liquid.

As per notification dated 23 February 2018, NPPA has fixed retail prices of 14 formulations under Drugs Prices Control Order, 2013.

[adsense:336x280:8701650588]

After KMC’s crackdown on unsafe packaged water, the state has made it mandatory for all such water units to have certification from two food-security authorities, besides the Bureau of Indian Standard (BIS) seal of approval.

Shri J P Nadda, Union Minister of Health and Family Welfare launched the ‘‘Viral Load testing for all People Living with HIV/AIDS (PLHIV),”at a function.
The initiative will provide free of cost viral load testing for 12 lakh PLHIV on treatment in the country at least once a year. Shri Nadda further announced that after ‘Treat All’, Viral Load test is a big step forward in treating and monitoring people living with HIV. “This Viral Load test is of immense importance to monitor the effectiveness of treatment of patients taking lifelong Antiretroviral Therapy,” he said.Smt. Anupriya Patel, Minister of State for Health & Family Welfare was also present at the launch function.

A new clinical study led by the National Eye Institute (NEI), part of the National Institutes of Health, will follow 500 people over five years to learn more about the natural history of early Age related macular degeneration (AMD).

With an aim to boost the medical equipment and devices sector, the State government has signed 25 MoUs. At the summit, a total of 25 MoUs worth Rs 5,090 crore with an employment opportunity of 4,750 jobs pertaining to the health sector were signed.

In the meeting, the MoS stressed on the need to increase the Viral Research Diagnostics Laboratories (VRDL) in the states, including UP. Smt. Anupriya Patel, Minister of State (Health & Family Welfare), in a high level meeting, reviewed the activities and achievements of Department of Health Research (DHR) and Indian Council of Medical Research (ICMR).  Dr. Sanjay Mehendale, Additional Director General, ICMR and Smt. Sarita Mittal Joint Secretary, Department of Health Research were also present.

Drug price regulator NPPA  said it has decided not to stop any coronary stent manufacturer from withdrawing products from the Indian market.

In the 78th meeting of the Drugs Technical Advisory Board (DTAB) held on 12th February, 2018 under the Chairmanship of the Director General of Health Services deliberated the directions of the Hon’ble Supreme Court of India dated 15.12.2017 in regard to the notifications issued by the Govt, of India prohibiting 344 FDCs +05 FDCs vide S.O.No. 705(E) to 1048 (E) dated 10.03.2016 and S.O. No. 1851(E) to 1855(E) dated 08.06.2017 respectively.

The Central Drugs Standard Control Organisation (CDSCO) has decided to make the regulations more stringent to tackle the menace of the widespread misuse of Oxytocin, a neurotransmitter and peptide hormone, in dairy and horticulture industry crop up on a daily basis. The Regulatory body will hold a crucial meeting on February 22 at 11:00Am in Delhi with all the manufacturers of Oxytocin formulation for human and animal use in the country.